Shoreline Biome announces international distribution partnership in Japan

FARMINGTON, Conn.— Shoreline Biome, a microbiome research company based here that develops tools for characterizing microbiome populations down to the strain level, has announced a distribution partnership with TOMY Digital Biology Co., Ltd., a leading Japanese biotech organization. TOMY provides high-quality instruments and services to industry segments including biotechnology, biological engineering, medical science, and food [...]

Cover open beakers and bottles securely with a colorful, stretchable lid

KIMBLE® Silicon Lids protect precious samples on a wide range of laboratory vessels while adding a splash of color to your lab MILLVILLE, NJ – Using aluminum foil or plastic wrap to cap beakers and flasks has always been a quick fix with questionable effectiveness. The new KIMBLE® Silicone Lids stretch and conform to beaker tops for [...]

CytomX Therapeutics Deploys Genedata Bioprocess

CytomX implements off-the-shelf Genedata workflow platform to accelerate development and manufacture of proprietary biotherapeutic modalities for cancer treatment SAN FRANCISCO (PRWEB) -- Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that CytomX Therapeutics, a clinical-stage oncology-focused biopharmaceutical company, has licensed Genedata Bioprocess® to act as an integrated workflow backbone for its [...]

ERS Genomics announces agreement with New England Biolabs to commercialize CRISPR gene editing tools and reagents

License agreement expands New England Biolabs’ rights to use and sell CRISPR/Cas9 reagents and tools DUBLIN, Ireland, and Ipswich MA, USA : ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property (IP) co-owned by Dr. Emmanuelle Charpentier, today announced it has signed an agreement with New England Biolabs (NEB®), [...]

Redesign Science and OpenEye Scientific announce strategic partnership

Partnership will advance both firms' positions in the field of molecular dynamics-based drug discovery NEW YORK and SANTA FE, N.M. -- Redesign Science and OpenEye Scientific are pleased to announce that they have entered into a strategic partnership to integrate OpenEye's pioneering Orion computational platform into Redesign's drug discovery platform. The practice of drug discovery has radically transformed [...]

genOway and Merck strengthen CRISPR/Cas9 strategic alliance by extending their partnership to all animal cell models

genOway acquires additional rights to develop all animal cell models using the CRISPR/Cas9 system Lyon, France - genOway, a public company and leader in developing genetically modified research models, today announced an important milestone in extending its strategic alliance with Merck, a leading science and technology company and leader in genome editing. In December 2018, genOway [...]

TwinStrand Biosciences Accelerates Commercialization with $16M in Series A Funding

SEATTLE -- TwinStrand Biosciences™, a novel genetic sequencing technology company, today announced the close of $16 million in Series A funding, including $12 million in new capital. Madrona Venture Group led the investment with participation from Alexandria Venture Investments, Ridgeback Capital and Sahsen Ventures. The funding will be used to accelerate the company's commercial pipeline, as well as to [...]

ArcherDX Appoints Mark Massaro Chief Financial Officer

BOULDER, Colo.— ArcherDX, Inc., a molecular diagnostics company developing breakthrough solutions to advance and enable the practice of personalized genomic medicine, today announced Mark Massaro has been appointed Chief Financial Officer. Mark Massaro, ArcherDX Chief Financial Officer “We are thrilled to welcome Mark to the ArcherDX team,” said Jason Myers, Chief Executive Officer. “Mark’s extensive [...]

TRILINK BIOTECHNOLOGIES EXPANDS IP PORTFOLIO WITH TWO NEW PATEN

Advancements Expected to Accelerate Development of mRNA Therapeutics SAN DIEGO – TriLink BioTechnologies, a Maravai LifeSciences company and a leader in the production of nucleic acids such as DNA and RNA, announced today that the United States Patent and Trademark Office has issued two new patents to the company. Both patents cover advancements in TriLink’s [...]

Paul Netzsch to expand the Executive Board of the NETZSCH Group

Selb – Paul Netzsch will be appointed Member of the Executive Board of Erich NETZSCH GmbH & Co. Holding KG as of 1 April 2020. With the 33-year-old business economist, one more member of the shareholder family will head the NETZSCH Group. In the future, Paul Netzsch along with Moritz Netzsch and Jens Niessner with [...]

Access IBO on Knowledge Center